img

Global GFP Antibody Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GFP Antibody Market Insights, Forecast to 2034

Antibodies are?proteins that protect you when an unwanted substance enters your body.
Market Analysis and InsightsGlobal GFP Antibody Market
Global GFP Antibody market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, GFP Antibody industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
A surge in research and development activities among pharmaceutical market leaders to develop economical andeffective antibodies and biosimilar antibodies is driving growth opportunities for the antibodies market.
Report Covers
This report presents an overview of global GFP Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global GFP Antibody market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Thermo Fisher Scientific
Aviva Systems Biology
Santa Cruz Biotechnology
Miltenyi Biotec
Proteintech
Synaptic Systems
NSJ Bioreagents
Medimabs
EXBIO
Bio X Cell
ProSci
United States Biological
Segment by Type
Polyclonal
Monoclonal

Segment by Application


Western Blot
Immunohistochemistry
Immunocytochemistry
Immunofluorescence
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, GFP Antibody introduction, etc. GFP Antibody Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of GFP Antibody
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GFP Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Polyclonal
1.2.3 Monoclonal
1.3 Market by Application
1.3.1 Global GFP Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Western Blot
1.3.3 Immunohistochemistry
1.3.4 Immunocytochemistry
1.3.5 Immunofluorescence
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GFP Antibody Market Perspective (2018-2029)
2.2 Global GFP Antibody Growth Trends by Region
2.2.1 GFP Antibody Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 GFP Antibody Historic Market Size by Region (2018-2024)
2.2.3 GFP Antibody Forecasted Market Size by Region (2024-2029)
2.3 GFP Antibody Market Dynamics
2.3.1 GFP Antibody Industry Trends
2.3.2 GFP Antibody Market Drivers
2.3.3 GFP Antibody Market Challenges
2.3.4 GFP Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue GFP Antibody by Players
3.1.1 Global GFP Antibody Revenue by Players (2018-2024)
3.1.2 Global GFP Antibody Revenue Market Share by Players (2018-2024)
3.2 Global GFP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of GFP Antibody, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global GFP Antibody Market Concentration Ratio
3.4.1 Global GFP Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GFP Antibody Revenue in 2022
3.5 Global Key Players of GFP Antibody Head office and Area Served
3.6 Global Key Players of GFP Antibody, Product and Application
3.7 Global Key Players of GFP Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GFP Antibody Breakdown Data by Type
4.1 Global GFP Antibody Historic Market Size by Type (2018-2024)
4.2 Global GFP Antibody Forecasted Market Size by Type (2024-2029)
5 GFP Antibody Breakdown Data by Application
5.1 Global GFP Antibody Historic Market Size by Application (2018-2024)
5.2 Global GFP Antibody Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America GFP Antibody Market Size (2018-2029)
6.2 North America GFP Antibody Market Size by Type
6.2.1 North America GFP Antibody Market Size by Type (2018-2024)
6.2.2 North America GFP Antibody Market Size by Type (2024-2029)
6.2.3 North America GFP Antibody Market Share by Type (2018-2029)
6.3 North America GFP Antibody Market Size by Application
6.3.1 North America GFP Antibody Market Size by Application (2018-2024)
6.3.2 North America GFP Antibody Market Size by Application (2024-2029)
6.3.3 North America GFP Antibody Market Share by Application (2018-2029)
6.4 North America GFP Antibody Market Size by Country
6.4.1 North America GFP Antibody Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America GFP Antibody Market Size by Country (2018-2024)
6.4.3 North America GFP Antibody Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe GFP Antibody Market Size (2018-2029)
7.2 Europe GFP Antibody Market Size by Type
7.2.1 Europe GFP Antibody Market Size by Type (2018-2024)
7.2.2 Europe GFP Antibody Market Size by Type (2024-2029)
7.2.3 Europe GFP Antibody Market Share by Type (2018-2029)
7.3 Europe GFP Antibody Market Size by Application
7.3.1 Europe GFP Antibody Market Size by Application (2018-2024)
7.3.2 Europe GFP Antibody Market Size by Application (2024-2029)
7.3.3 Europe GFP Antibody Market Share by Application (2018-2029)
7.4 Europe GFP Antibody Market Size by Country
7.4.1 Europe GFP Antibody Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe GFP Antibody Market Size by Country (2018-2024)
7.4.3 Europe GFP Antibody Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China GFP Antibody Market Size (2018-2029)
8.2 China GFP Antibody Market Size by Type
8.2.1 China GFP Antibody Market Size by Type (2018-2024)
8.2.2 China GFP Antibody Market Size by Type (2024-2029)
8.2.3 China GFP Antibody Market Share by Type (2018-2029)
8.3 China GFP Antibody Market Size by Application
8.3.1 China GFP Antibody Market Size by Application (2018-2024)
8.3.2 China GFP Antibody Market Size by Application (2024-2029)
8.3.3 China GFP Antibody Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia GFP Antibody Market Size (2018-2029)
9.2 Asia GFP Antibody Market Size by Type
9.2.1 Asia GFP Antibody Market Size by Type (2018-2024)
9.2.2 Asia GFP Antibody Market Size by Type (2024-2029)
9.2.3 Asia GFP Antibody Market Share by Type (2018-2029)
9.3 Asia GFP Antibody Market Size by Application
9.3.1 Asia GFP Antibody Market Size by Application (2018-2024)
9.3.2 Asia GFP Antibody Market Size by Application (2024-2029)
9.3.3 Asia GFP Antibody Market Share by Application (2018-2029)
9.4 Asia GFP Antibody Market Size by Region
9.4.1 Asia GFP Antibody Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia GFP Antibody Market Size by Region (2018-2024)
9.4.3 Asia GFP Antibody Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America GFP Antibody Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America GFP Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America GFP Antibody Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America GFP Antibody Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America GFP Antibody Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America GFP Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America GFP Antibody Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America GFP Antibody Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America GFP Antibody Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America GFP Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America GFP Antibody Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America GFP Antibody Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America GFP Antibody Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific GFP Antibody Introduction
11.1.4 Thermo Fisher Scientific Revenue in GFP Antibody Business (2018-2024)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Aviva Systems Biology
11.2.1 Aviva Systems Biology Company Details
11.2.2 Aviva Systems Biology Business Overview
11.2.3 Aviva Systems Biology GFP Antibody Introduction
11.2.4 Aviva Systems Biology Revenue in GFP Antibody Business (2018-2024)
11.2.5 Aviva Systems Biology Recent Developments
11.3 Santa Cruz Biotechnology
11.3.1 Santa Cruz Biotechnology Company Details
11.3.2 Santa Cruz Biotechnology Business Overview
11.3.3 Santa Cruz Biotechnology GFP Antibody Introduction
11.3.4 Santa Cruz Biotechnology Revenue in GFP Antibody Business (2018-2024)
11.3.5 Santa Cruz Biotechnology Recent Developments
11.4 Miltenyi Biotec
11.4.1 Miltenyi Biotec Company Details
11.4.2 Miltenyi Biotec Business Overview
11.4.3 Miltenyi Biotec GFP Antibody Introduction
11.4.4 Miltenyi Biotec Revenue in GFP Antibody Business (2018-2024)
11.4.5 Miltenyi Biotec Recent Developments
11.5 Proteintech
11.5.1 Proteintech Company Details
11.5.2 Proteintech Business Overview
11.5.3 Proteintech GFP Antibody Introduction
11.5.4 Proteintech Revenue in GFP Antibody Business (2018-2024)
11.5.5 Proteintech Recent Developments
11.6 Synaptic Systems
11.6.1 Synaptic Systems Company Details
11.6.2 Synaptic Systems Business Overview
11.6.3 Synaptic Systems GFP Antibody Introduction
11.6.4 Synaptic Systems Revenue in GFP Antibody Business (2018-2024)
11.6.5 Synaptic Systems Recent Developments
11.7 NSJ Bioreagents
11.7.1 NSJ Bioreagents Company Details
11.7.2 NSJ Bioreagents Business Overview
11.7.3 NSJ Bioreagents GFP Antibody Introduction
11.7.4 NSJ Bioreagents Revenue in GFP Antibody Business (2018-2024)
11.7.5 NSJ Bioreagents Recent Developments
11.8 Medimabs
11.8.1 Medimabs Company Details
11.8.2 Medimabs Business Overview
11.8.3 Medimabs GFP Antibody Introduction
11.8.4 Medimabs Revenue in GFP Antibody Business (2018-2024)
11.8.5 Medimabs Recent Developments
11.9 EXBIO
11.9.1 EXBIO Company Details
11.9.2 EXBIO Business Overview
11.9.3 EXBIO GFP Antibody Introduction
11.9.4 EXBIO Revenue in GFP Antibody Business (2018-2024)
11.9.5 EXBIO Recent Developments
11.10 Bio X Cell
11.10.1 Bio X Cell Company Details
11.10.2 Bio X Cell Business Overview
11.10.3 Bio X Cell GFP Antibody Introduction
11.10.4 Bio X Cell Revenue in GFP Antibody Business (2018-2024)
11.10.5 Bio X Cell Recent Developments
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci GFP Antibody Introduction
11.11.4 ProSci Revenue in GFP Antibody Business (2018-2024)
11.11.5 ProSci Recent Developments
11.12 United States Biological
11.12.1 United States Biological Company Details
11.12.2 United States Biological Business Overview
11.12.3 United States Biological GFP Antibody Introduction
11.12.4 United States Biological Revenue in GFP Antibody Business (2018-2024)
11.12.5 United States Biological Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global GFP Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Polyclonal
Table 3. Key Players of Monoclonal
Table 4. Global GFP Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global GFP Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global GFP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global GFP Antibody Market Share by Region (2018-2024)
Table 8. Global GFP Antibody Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global GFP Antibody Market Share by Region (2024-2029)
Table 10. GFP Antibody Market Trends
Table 11. GFP Antibody Market Drivers
Table 12. GFP Antibody Market Challenges
Table 13. GFP Antibody Market Restraints
Table 14. Global GFP Antibody Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global GFP Antibody Revenue Share by Players (2018-2024)
Table 16. Global Top GFP Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2022)
Table 17. Global GFP Antibody Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by GFP Antibody Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of GFP Antibody, Headquarters and Area Served
Table 20. Global Key Players of GFP Antibody, Product and Application
Table 21. Global Key Players of GFP Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global GFP Antibody Revenue Market Share by Type (2018-2024)
Table 25. Global GFP Antibody Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global GFP Antibody Revenue Market Share by Type (2024-2029)
Table 27. Global GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global GFP Antibody Revenue Share by Application (2018-2024)
Table 29. Global GFP Antibody Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global GFP Antibody Revenue Share by Application (2024-2029)
Table 31. North America GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America GFP Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America GFP Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America GFP Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe GFP Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe GFP Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe GFP Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 45. China GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 46. China GFP Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 47. China GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 48. China GFP Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia GFP Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia GFP Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia GFP Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia GFP Antibody Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia GFP Antibody Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America GFP Antibody Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America GFP Antibody Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America GFP Antibody Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America GFP Antibody Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America GFP Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America GFP Antibody Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America GFP Antibody Market Size by Country (2024-2029) & (US$ Million)
Table 63. Thermo Fisher Scientific Company Details
Table 64. Thermo Fisher Scientific Business Overview
Table 65. Thermo Fisher Scientific GFP Antibody Product
Table 66. Thermo Fisher Scientific Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 67. Thermo Fisher Scientific Recent Developments
Table 68. Aviva Systems Biology Company Details
Table 69. Aviva Systems Biology Business Overview
Table 70. Aviva Systems Biology GFP Antibody Product
Table 71. Aviva Systems Biology Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 72. Aviva Systems Biology Recent Developments
Table 73. Santa Cruz Biotechnology Company Details
Table 74. Santa Cruz Biotechnology Business Overview
Table 75. Santa Cruz Biotechnology GFP Antibody Product
Table 76. Santa Cruz Biotechnology Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 77. Santa Cruz Biotechnology Recent Developments
Table 78. Miltenyi Biotec Company Details
Table 79. Miltenyi Biotec Business Overview
Table 80. Miltenyi Biotec GFP Antibody Product
Table 81. Miltenyi Biotec Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 82. Miltenyi Biotec Recent Developments
Table 83. Proteintech Company Details
Table 84. Proteintech Business Overview
Table 85. Proteintech GFP Antibody Product
Table 86. Proteintech Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 87. Proteintech Recent Developments
Table 88. Synaptic Systems Company Details
Table 89. Synaptic Systems Business Overview
Table 90. Synaptic Systems GFP Antibody Product
Table 91. Synaptic Systems Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 92. Synaptic Systems Recent Developments
Table 93. NSJ Bioreagents Company Details
Table 94. NSJ Bioreagents Business Overview
Table 95. NSJ Bioreagents GFP Antibody Product
Table 96. NSJ Bioreagents Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 97. NSJ Bioreagents Recent Developments
Table 98. Medimabs Company Details
Table 99. Medimabs Business Overview
Table 100. Medimabs GFP Antibody Product
Table 101. Medimabs Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 102. Medimabs Recent Developments
Table 103. EXBIO Company Details
Table 104. EXBIO Business Overview
Table 105. EXBIO GFP Antibody Product
Table 106. EXBIO Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 107. EXBIO Recent Developments
Table 108. Bio X Cell Company Details
Table 109. Bio X Cell Business Overview
Table 110. Bio X Cell GFP Antibody Product
Table 111. Bio X Cell Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 112. Bio X Cell Recent Developments
Table 113. ProSci Company Details
Table 114. ProSci Business Overview
Table 115. ProSci GFP Antibody Product
Table 116. ProSci Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 117. ProSci Recent Developments
Table 118. United States Biological Company Details
Table 119. United States Biological Business Overview
Table 120. United States Biological GFP Antibody Product
Table 121. United States Biological Revenue in GFP Antibody Business (2018-2024) & (US$ Million)
Table 122. United States Biological Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GFP Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global GFP Antibody Market Share by Type: 2022 VS 2029
Figure 3. Polyclonal Features
Figure 4. Monoclonal Features
Figure 5. Global GFP Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global GFP Antibody Market Share by Application: 2022 VS 2029
Figure 7. Western Blot Case Studies
Figure 8. Immunohistochemistry Case Studies
Figure 9. Immunocytochemistry Case Studies
Figure 10. Immunofluorescence Case Studies
Figure 11. Others Case Studies
Figure 12. GFP Antibody Report Years Considered
Figure 13. Global GFP Antibody Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global GFP Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GFP Antibody Market Share by Region: 2022 VS 2029
Figure 16. Global GFP Antibody Market Share by Players in 2022
Figure 17. Global Top GFP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFP Antibody as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by GFP Antibody Revenue in 2022
Figure 19. North America GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America GFP Antibody Market Share by Type (2018-2029)
Figure 21. North America GFP Antibody Market Share by Application (2018-2029)
Figure 22. North America GFP Antibody Market Share by Country (2018-2029)
Figure 23. United States GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe GFP Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe GFP Antibody Market Share by Type (2018-2029)
Figure 27. Europe GFP Antibody Market Share by Application (2018-2029)
Figure 28. Europe GFP Antibody Market Share by Country (2018-2029)
Figure 29. Germany GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China GFP Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China GFP Antibody Market Share by Type (2018-2029)
Figure 37. China GFP Antibody Market Share by Application (2018-2029)
Figure 38. Asia GFP Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia GFP Antibody Market Share by Type (2018-2029)
Figure 40. Asia GFP Antibody Market Share by Application (2018-2029)
Figure 41. Asia GFP Antibody Market Share by Region (2018-2029)
Figure 42. Japan GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America GFP Antibody Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America GFP Antibody Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America GFP Antibody Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America GFP Antibody Market Share by Country (2018-2029)
Figure 52. Brazil GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries GFP Antibody Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 59. Aviva Systems Biology Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 60. Santa Cruz Biotechnology Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 61. Miltenyi Biotec Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 62. Proteintech Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 63. Synaptic Systems Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 64. NSJ Bioreagents Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 65. Medimabs Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 66. EXBIO Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 67. Bio X Cell Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 68. ProSci Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 69. United States Biological Revenue Growth Rate in GFP Antibody Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed